+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Connective Tissue Growth Factor"

Connective Tissue Growth Factor - Pipeline Review, H2 2019 - Product Thumbnail Image

Connective Tissue Growth Factor - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 83 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Connective Tissue Growth Factor (CTGF) is a protein involved in the regulation of cell growth and differentiation. It is a key component of the extracellular matrix and is involved in the development of endocrine and metabolic disorders. CTGF is involved in the regulation of glucose and lipid metabolism, and is also involved in the regulation of insulin sensitivity. It is also involved in the regulation of bone and cartilage formation, and in the regulation of wound healing. CTGF is a promising target for the development of drugs for endocrine and metabolic disorders. Several companies are developing CTGF-based therapies for the treatment of diabetes, obesity, and other metabolic disorders. These include Novo Nordisk, Sanofi, and Merck. Other companies such as Amgen, Pfizer, and Eli Lilly are also researching CTGF-based therapies for the treatment of endocrine and metabolic disorders. Show Less Read more